Sucralfate (Carafate) and Melena (Black, Tarry Stools)
Carafate (sucralfate) is not identified as a typical cause of melena (black, tarry stools) in the drug’s prescribing information. [1] Black or tarry stool (melena) is classically associated with upper gastrointestinal bleeding and should prompt clinical evaluation rather than attribution to sucralfate. [2]
Sucralfate Adverse Effects Relevant to Stool Color
In clinical trial adverse reactions for sucralfate, constipation and GI symptoms such as diarrhea, nausea, vomiting, gastric discomfort, indigestion, and flatulence are reported. [1] Black or tarry stool is not listed as a reported adverse effect in the Carafate prescribing information adverse-reaction section. [1]
Typical Causes of Melena
Melena is generally treated as a sign of digested blood from an upper GI source. [2] Non-bleeding causes of dark stool exist, but melena is specifically concerning for GI bleeding and is evaluated with appropriate testing. [2]
Clinical Approach When Dark Stools Occur During Sucralfate Use
Melena characterized as black, tarry stools should be assessed for upper GI bleeding rather than assumed to be medication-related. [2] Urgent evaluation is indicated if dark stools are accompanied by symptoms suggestive of bleeding (for example, weakness, lightheadedness, or vomiting of blood/coffee-ground material) or if the stool appearance is persistently tarry. [2]
When Reassurance Is More Reasonable
If stool darkening is mild and not tarry, and there are alternative explanations (dietary factors or other dark-stool medications), the cause may be non-bleeding, but melena-like stool appearance still warrants evaluation. [2]
Medication Safety Considerations
If sucralfate is being used for ulcer treatment, new melena should be treated as a potential complication of ulcer disease until GI bleeding is excluded. [2]